Checkpoint Therapeutics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 05/14/2024   Download
SEC Document
SEC Filing

As described under Item 5.07 of this Current Report, on May 13, 2024, the stockholders of the Company voted at the 2024 Annual Meeting to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock authorized for issuance by 95,000,000 shares, bringing the total number of authorized shares of common stock to 175,000,000 shares (the “Amendment”).

On May 13, 2024, following the 2024 Annual Meeting, the Company filed a certificate of amendment (the “Certificate”) giving effect to the Amendment with the Secretary of State of the State of Delaware.